Similarly, SETBP1 mutations were more common in patients with CMML-MP compared with patients with CMML-MD (23 % vs. 8 %, P = 0.023, respectively) (Fig. 1a). The gene discussed is SETBP1; the disease is chronic myelomonocytic leukemia.